Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110048169 | 11004816 | 9 | F | 20160907 | 20150409 | 20160920 | EXP | US-PFIZER INC-2015119053 | PFIZER | 69.00 | YR | M | Y | 83.00000 | KG | 20160920 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110048169 | 11004816 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG CYCLIC | 21938 | 50 | MG | CAPSULE, HARD | ||||||||
| 110048169 | 11004816 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG CYCLIC (DAILY,28 DAYS ON /14 DAYS OFF) | 21938 | 37.5 | MG | CAPSULE, HARD | ||||||||
| 110048169 | 11004816 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG CYCLIC (28 DAYS ON /2 WEEKS OFF) (12.5MG THREE CAPSULES BY MOUTH ONCE IN THE MORNING) | 082BA | 21938 | 37.5 | MG | CAPSULE, HARD | ||||||
| 110048169 | 11004816 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 110048169 | 11004816 | 5 | C | GLIPIZIDE. | GLIPIZIDE | 1 | UNK | 0 | |||||||||||
| 110048169 | 11004816 | 6 | C | PRAVASTATIN. | PRAVASTATIN | 1 | UNK | 0 | |||||||||||
| 110048169 | 11004816 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | |||||||||||
| 110048169 | 11004816 | 8 | C | METOPROLOL. | METOPROLOL | 1 | UNK | 0 | |||||||||||
| 110048169 | 11004816 | 9 | C | MAGIC MOUTHWASH | DIPHENHYDRAMINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDENYSTATIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110048169 | 11004816 | 1 | Renal cancer metastatic |
| 110048169 | 11004816 | 2 | Renal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110048169 | 11004816 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110048169 | 11004816 | Blister | |
| 110048169 | 11004816 | Blood glucose increased | |
| 110048169 | 11004816 | Drug prescribing error | |
| 110048169 | 11004816 | Dry skin | |
| 110048169 | 11004816 | Dysgeusia | |
| 110048169 | 11004816 | Fatigue | |
| 110048169 | 11004816 | Glossodynia | |
| 110048169 | 11004816 | Hyperaesthesia | |
| 110048169 | 11004816 | Musculoskeletal discomfort | |
| 110048169 | 11004816 | Oral pain | |
| 110048169 | 11004816 | Rash | |
| 110048169 | 11004816 | Skin exfoliation | |
| 110048169 | 11004816 | Skin hypertrophy | |
| 110048169 | 11004816 | Skin reaction | |
| 110048169 | 11004816 | Stomatitis | |
| 110048169 | 11004816 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110048169 | 11004816 | 1 | 20150201 | 0 | ||
| 110048169 | 11004816 | 2 | 20150318 | 0 | ||
| 110048169 | 11004816 | 9 | 20150217 | 0 |